Final Results

RNS Number : 1961M
Bankers Investment Trust PLC
18 January 2016
 

 

THE BANKERS INVESTMENT TRUST PLC

Annual Financial Report for the year ended 31 October 2015

 

This announcement contains regulated information

 

Chairman's Statement

 

Net asset value increase of 5.7%

Dividend increase of 6.8%

49th consecutive year of dividend increases

Forecast increase in 2016 dividend of at least 4.4%

20 year £50m strategic debt issue at an annualised coupon rate of 3.68%

 

Performance

I sounded a cautionary tone in my "Outlook" section last year regarding the prospects for stock markets making much progression against a backdrop of growing global macro-economic uncertainty. Despite this uncertainty I am pleased to able to report that our Fund Manager and his team, through a combination of judicious stock selection and asset allocation, have been able to add significant value against virtually every local market index in which Bankers' assets are invested (the only exception being the small asset allocation to emerging markets).

This is an excellent result for shareholders and reflects the disciplined focus of the investment team in regard to stock selection and upon medium to longer term investment themes and trends.

 

During the year we have continued to shift our allocation away from the domestic UK equity market and have consequently increased our overseas equity exposure, in particular towards North America and Japan. This deliberate policy shift will continue and I would expect the UK equity market exposure to settle at approximately 30% during the forthcoming year. Overseas markets offer Bankers' an ability to gain greater exposure to higher growth sectors and to global companies within these sectors. As these companies grow their earnings we expect their dividend growth potential to be equal or greater than that to be achieved from our UK equity portfolio. Further detail as to individual market reports can be in the Fund Manager reports section of the Annual Report.

 

Revenue and Dividends

Special dividends have continued to help our revenue account this year and this, alongside strong underlying dividend growth across the portfolio, has enabled the Board to recommend a final quarterly dividend of 4.0p per share. If approved by shareholders, this will result in a total dividend payment of 15.8p per share, an increase of 6.8%. This is a pleasing outcome and should be viewed against my forecast last year of an increase of at least 4%. Our earnings per share for the period were 17.22p.

 

Looking to the current year we have some conflicting signals for underlying dividend growth. On the positive is the stock selection approach which the Fund Manager has taken, which emphasises companies that have the ability to grow their dividends over the medium term. On the negative is the potential wider global economic slowdown which has already dampened, and could further dampen, market dividend growth expectations. Despite this mixed backdrop the Board is confident in predicting dividend growth of at least 4.4% for 2016, representing a minimum total dividend for the year of over 16.5p per share.

 

Long Term Debt

During the year the Board took the decision to increase structurally the Company's fixed debt. There were two key drivers of this. Namely the historically low level of interest rates which Bankers could lock into and the redemption next year of one of our existing debentures, the £10 million 10.5% issued at a time when interest rates and inflation were at significantly higher levels than today.

 

 

 

 

We were able to issue 20 year 3.68% £50m loan notes. This cost approximates to the market dividend yield today. So, when we invest the monies into selected holdings shareholders should be able to benefit from all future dividend growth. At the time of writing some of these funds have been invested but we remain patient in regard to investing the balance. Once fully invested the maximum fixed gearing of the Company would increase to 10%, a level with which your Board remains comfortable.

 

Annual General Meeting ("AGM')

The AGM this year will again be held at Trinity House, London, EC3N 4DH on 25 February 2016 at 12 noon. Full details of the business to be conducted at the meeting are set out in the Notice of Meeting which will be sent to shareholders with the Annual Report. Directions and a map showing the location of the AGM can also be found in the Notice of Meeting. The Board looks forward to seeing many shareholders at this meeting at which Alex Crooke and his investment team will present their investment views and how these are reflected in the portfolio. Following the formal business of the meeting light refreshments will be served.

 

Outlook

As for the future, I remain cautious! I continue to see headwinds across the globe from both a political and an economic perspective. Some of these, such as low economic growth, disinflation and falling commodity prices have been with us for many months if not years and new ones will emerge in the year ahead such as the UK's membership of the EU. But what I also continue to observe is that by taking the medium to long term view on companies and major economies one can escape the "noise" and focus on building on the returns that have been achieved by the current investment team and their predecessors. These returns also reflect the power of compounding which should never be underestimated and this can be powerfully demonstrated by our dividend growth record of 92% over the past ten years and our net asset value growth record of 73%. I think you will agree these are impressive figures, especially when you compare them with the ten year return of the Retail Prices Index of 34% and the FTSE All-Share Index return of 30%.

 

So looking ahead over the next year is actually really quite a short time span in the context of what our investment team are trying to achieve and, indeed, the context of the life of Bankers Investment Trust. Markets will rise, and will fall, and they remain unpredictable which in turn has the ability to negatively impact investor sentiment. However, as long as the underlying companies in which we invest are sound and improving, then we should remain optimistic for the long term. As I stated in my report last year and, as has been borne out this year, patience and careful stock selection will again be a key requisite for outperformance in the year ahead.

 

Richard Killingbeck

Chairman

Principal Risks and Uncertainties

The Board, with the assistance of Henderson, has carried out a robust assessment of the principal risks facing the Company including those that would threaten its business model, future performance, solvency or liquidity. The Board has drawn up a matrix of risks facing the Company and has put in place a schedule of investment limits and restrictions, appropriate to the Company's investment objective and policy, in order to mitigate these risks as far as practicable. The principal risks which have been identified, and the steps taken by the Board to mitigate these as far as practicable, and whether the Board considers the impact of such risks has changed over the past year, are as follows:

 

Controls and Mitigation

 

The Board monitors investment performance at each Board meeting and regularly reviews the extent of its borrowings.

 

The Fund Manager seeks to maintain a diversified portfolio to mitigate against this risk. The Board regularly reviews the portfolio, investment activity and performance.

 

Henderson has contracted to provide investment, company secretarial, administration and accounting services through qualified professionals. The Board receives internal control reports produced by Henderson on a quarterly basis, which confirm regulatory compliance.

 

The Company minimises the risk of a counterparty failing to deliver securities or cash by dealing through organisations that have undergone rigorous due diligence by Henderson. The Company has a diversified portfolio which comprises mainly investments in large and medium-sized companies and mitigates the Company's exposure to liquidity risk.

 

The Board monitors the services provided by Henderson and its other suppliers and receives reports on the key elements in place to provide effective internal control.

 

The Board considers these risks to have remained unchanged throughout the year under review.

 

 

Viability Statement

The Directors have assessed the viability of the Company over a three year period, taking account of the Company's current position and the potential impact of the principal risks and uncertainties documented in this Strategic Report.

 

The Directors conducted the assessment based on a period of three years because they consider this to be an appropriate period over which they do not expect there to be any significant change in the current principal risks and adequacy of the mitigating controls in place. Also the Directors do not envisage any change in strategy or objectives or any events that would prevent the Company from continuing to operate over that period as the Company's assets are liquid, its commitments

are limited and the Company intends to continue to operate as an investment trust.

 

The assessment has considered the impact of the likelihood of the principal risks and uncertainties facing the Company, in particular Investment Activity and Performance, Portfolio and Market and

Financial risks, in severe but plausible scenarios, and the effectiveness of any mitigating controls in place.

 

The Directors also took into account the liquidity of the portfolio, the gearing and the income stream from the portfolio in considering the viability of the Company over the next three years and its ability to meet liabilities as they fall due. This included consideration of the duration of the Company's long term borrowings, how the forecast income stream, expenditure and levels of reserves could impact on the Company's ability to pay dividends to shareholders over that period in line with its current dividend policy. Whilst detailed forecasts are only made over a shorter time frame, the nature of the Company's business as an investment trust means that such forecasts are equally valid to be considered over the longer three year period as a means of assessing whether the Company can continue in operation. This included consideration of the duration of the Company's fixed term debt and how a breach of the gearing covenants could impact on the Company's net asset value and share price.

 

Based on their assessment, the Directors have a reasonable expectation that the Company will be able to continue in operation and meet its liabilities as they fall due over the next three year period. Only a substantial financial crisis affecting the global economy could have an impact on this assessment.

 

Related Party Transactions

The Company's transactions with related parties in the year were with its Directors and Henderson. There have been no material transactions between the Company and its Directors during the year other than the amounts paid to them in respect of Directors' remuneration for which there were no outstanding amounts payable at the year end. In relation to the provision of services by Henderson, other than fees payable by the Company in the ordinary course of business and the provision of sales and marketing services, there have been no transactions with Henderson affecting the financial position of the Company during the year under review.

 

Statement of Directors' Responsibilities under DTR 4.1.12

Each of the Directors confirms that, to the best of his or her knowledge:

 

• the Company's financial statements, which have been prepared in accordance with IFRSs as adopted by the European Union, give a true and fair view of the assets, liabilities, financial position and profit of the Company; and

 

• the Strategic Report in the Annual Report and financial statements includes a fair review of the development and performance of the business and the position of the Company, together with a description of the principal risks and uncertainties that it faces.

 

For and on behalf of the Board of Directors

 

Richard Killingbeck

Chairman

 

 

 

Fund Manager's Review

To some extent this last year has mirrored the previous year in terms of a lack of sustainable growth, low inflation and dull investment returns. There was the usual bout of enthusiasm at the start of the year but stock markets peaked around April/May and took a turn down in the later summer. All through the recovery from the 2008-9 financial crash, there has been a distinct lack of demand by consumers and corporates, partly a result of a dysfunctional banking sector but also due to high levels of unemployment and a lack of wage growth. The effects of this poor demand profile were shown up in the significant crash in the oil prices and mirrored in other commodities. The oil price fell sharply through the second half of 2014 and was $81 a barrel at the start of our financial year on 1 November 2014 but still nearly halved in value from there, a year later at $47. Ultimately this fall should feed through to greater spending power for consumers around the world but this will take time and stock markets reacted quicker, forcing down prices for oil and commodity stocks.

 

We have had to tread carefully this year avoiding too much exposure to commodities and side stepping a number of profit warnings across many sectors, which generally were caused by the weak growth in the major economies. Our efforts were ultimately rewarded in that all of our major geographic portfolios exceeded their local benchmark indices, (with special mention to the US outperforming by 5.5%, Europe by 7.3% and Japan by 10.1%). Only the Emerging Market sleeve missed its benchmark, underperforming by 7.4% where we had too much exposure to Latin America and were impacted in particular by the fall in currencies.

 

It is worth reviewing the two strategic changes we implemented in the previous year, namely a change of investment style and manager in the US and initial investments in Chinese "A" shares. The US portfolio is undoubtedly now more growth orientated but we believe that the US economy is entering a period of steady recovery and a growth bias should reward us better in terms of returns. The portfolio has a lower dividend yield than the market but should grow more quickly, while the overall valuation in terms of P/E for the US portfolio is below that of the index. In the first full year of performance the portfolio produced a sterling return of 12.7% against 7.2% for the index. We have some exciting investments which are positioned in areas that we expect to exhibit strong growth and should be less exposed to increasing US interest rates. The Chinese portfolio had a very volatile year but still exceeded all our expectations. We started this investment to gain greater exposure to the growth in Chinese consumer spending and because we felt share prices were extremely cheap by historic standards. We didn't think that the market would recover so strongly but prices quickly ran ahead of fundamentals. Even with the setback in the market over the summer, our portfolio produced a return of 51.7% over the year and valuations still look appealing with an attractive dividend yield. We now have roughly 20% cash in the Chinese QFII account and a more cautious mix of stocks compared to a year ago.

 

 

For a number of years we have been carefully monitoring the cost of long term debt for Investment Companies. The coupons have steadily fallen and this year we decided to move after the coupon on long term borrowings fell below 4%. Our £10 million 10.5% long term debenture will be repaid in October 2016 and we have prefunded this debenture payment with the issue of £50 million of 20 year loan notes in May. The 3.68% coupon on these notes will be close to the dividend yield on new investments and should enhance returns for shareholders over time. In the short term we have repaid and cancelled our short term borrowing facility with Commonwealth Bank of Australia as we do not need the funds and this avoids extra costs. In time we can add extra short term borrowings when needed. The new loan notes increase our fully invested gearing position to roughly 10% but, at the year end, we still retained the bulk of the new funds, accepting an element of "cash drag" while awaiting suitable buying opportunities. Net gearing was 2%.

 

 

 

 

 

 

 

All year we have been cautious on Emerging Markets and Asia, reflecting pressures on commodity prices and slowing growth in China. The investment in both areas was reduced, most noticeably in

Asia which fell to 11.3% of the portfolio. Extra funds were invested into Europe and Japan. The latter was the best performing of the major regions and there is some good evidence that "Abenomics" is working. Corporate profits have been recovering and valuations are at historically low levels reflecting the market's scepticism. North America now accounts for 25.4% of the portfolio mainly through good performance while the UK allocation continues to be reduced. If all of the available funds were invested outside the UK the allocation would fall to 35%.

 

The UK remains a key market for income generation and produced a larger number of special dividends which boosted our overall income by over £2m. This has been an exceptional year for specials and is a function of low growth in that companies have limited need to invest new capital. We expect further special dividends in the coming year but not to the same extent. The Company's income was boosted by US dollar currency gains and some of our recent regional allocation movements. A further positive factor in recent years has been an investment focus on companies that have the capacity to increase dividends and this is now generating good returns. Pressure on dividends is undoubtedly rising in the commodity sectors and, while major oil companies will keep their dividends for a time, we will see some stress this year if the price of oil stays below $50 a barrel. We are keeping a cautious eye on markets to judge the right time to invest the cash balances from the loan notes issue and also to protect our investment income.

 

Alex Crooke

Fund Manager

 

 

 

 

 

 

 

 

 

For further information contact:                                             

 

Alex Crooke

Fund Manager

The Bankers Investment Trust PLC

Telephone: 020 7818 4447

 

Richard Killingbeck

Chairman

The Bankers Investment Trust PLC

Telephone: 020 7818 4233

James de Sausmarez

Director of Investment Trusts

Henderson Investment Funds Limited

Telephone: 020 7818 3349

Sarah Gibbons-Cook

Investor Relations and PR Manager

Henderson Global Investors Limited

Telephone: 020 7818 3198



 

 

 

 

 

Performance Highlights 

 

31 October  

2015

Change since

31 October

2014

Net Asset Value per share

630.2p

+5.7%

Share price

618.5p

+9.9%

Total Assets (less current liabilities)

£777.4m

+12.1%

Dividend for year(1)

15.8p

+6.8%

Revenue return per share

17.2p

+13.9%





31 October

2015

31 October

2014

Dividend yield(2)

2.6%

2.6%

Net gearing

2.0%

2.6%

Ongoing charge

0.52%

0.53%

Retail Prices Index increase over year

0.7%

2.3%

Discount at year end

1.9%

5.5%

 

(1)   This represents the four ordinary dividends recommended or paid for the year.

(2)   Based on the share price at the year end.

 

Sources: Morningstar for the AIC, Henderson, Datastream.

                                               


 

STATEMENT OF COMPREHENSIVE INCOME

 

 


Year ended 31 October 2015

Year ended 31 October 2014


 

 

Notes

Revenue return £'000

Capital return £'000

 

Total £'000

Revenue return £'000

Capital return £'000

 

Total

£'000

Gains on investments held at fair value through profit or loss

 

 

-

40,745

40,745

 

-

 

11,615

 

11,615

Investment income

2

22,621

-

22,621

20,577

-

20,577

Other operating income

3

146

17

163

171

-

171



---------

---------

---------

---------

---------

---------

Total income


22,767

40,762

63,529

20,748

11,615

32,363



---------

---------

---------

---------

---------

---------

Expenses








Management fees

4

(892)

(2,082)

(2,974)

(1,726)

(929)

(2,655)

Other expenses


(788)

(7)

(795)

(720)

-

(720)



---------

---------

---------

---------

---------

---------

Profit before finance costs and taxation


21,087

38,673

59,760

 

18,302

 

10,686

 

28,988









Finance costs


(925)

(2,157)

(3,082)

(685)

(1,598)

(2,283)



---------

---------

---------

---------

---------

---------

Profit before taxation


20,162

36,516

56,678

17,617

9,088

26,705









Taxation

5

(849)

(6)

(855)

(775)

-

(775)



---------

---------

---------

---------

---------

---------

Profit for the year and total comprehensive income


19,313

36,510

55,823

 

16,842

 

9,088

 

25,930



=====

======

======

=====

======

======

Earnings per ordinary share - basic and diluted

6

17.22p

32.54p

49.76p

 

15.05p

 

8.12p

 

23.17p

 

 

The total columns of this statement represent the Statement of Comprehensive Income, prepared in accordance with IFRSs as adopted by the European Union.  The revenue return and capital return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies. 

 

 

 

 

 

 

 

 


 

 

STATEMENT OF CHANGES IN EQUITY

 

 

 

Year ended

31 October 2015

 Called up

share capital

£'000

 Share premium

account

£'000

Capital  redemption

reserve

£'000

Other capital

reserves

£'000

 

 Revenue reserve

£'000

 

Total

equity

£'000

Total equity at 1 November 2014

28,027

7,053

12,483

587,744

32,889

668,196

Total comprehensive income:







Profit for the year

-

-

-

36,510

19,313

55,823

Transactions with owners, recorded directly to equity:







Issue of 1,000,000 ordinary shares

250

5,669

-

-

-

5,919

Buy-back of 25,000 ordinary shares

(6)

-

6

(155)

-

(155)

Ordinary dividends paid

-

-

-

-

(17,150)

(17,150)


----------

----------

----------

----------

----------

----------

Total equity at 31 October 2015

28,271

12,722

12,489

624,099

35,052

712,633


======

======

======

======

======

======

 

 

 

Year ended

31 October 2014

 Called up

share capital

£'000

 Share premium

account

£'000

Capital  redemption

reserve

£'000

Other capital

reserves

£'000

 

 Revenue reserve

£'000

 

Total

equity

£'000

Total equity at 1 November 2013

27,814

2,352

12,483

578,656

32,256

653,561

Total comprehensive income:







Profit for the year

-

-

-

9,088

16,842

25,930

Transactions with owners, recorded directly to equity:







Issue of 850,000 ordinary shares

213

4,701

-

-

-

4,914

Ordinary dividends paid

-

-

-

-

(16,209)

(16,209)


----------

----------

----------

----------

----------

----------

Total equity at 31 October 2014

28,027

7,053

12,483

587,744

32,889

668,196


======

======

======

======

======

======

 


 

 

STATEMENT OF FINANCIAL POSITION

 




 

At 31 October

2015

£'000

 

At 31 October

2014

£'000






Non-current assets





Investments held at fair value through profit or loss



726,831

685,456




-----------

-----------






Current assets





Investments held at fair value through profit or loss



28,323

3,896

Other receivables



2,360

3,685

Cash and cash equivalents



31,762

5,023




-----------

-----------




62,445

12,604




-----------

-----------

Total assets



789,276

698,060




-----------

-----------

Current liabilities





Bank loans



-

(2,788)

Other payables



(1,848)

(2,076)

Debenture stocks



(10,000)

-




----------

----------




    (11,848)

(4,864)




----------

----------

Total assets less current liabilities



777,428

693,196




-----------

-----------

Non-current liabilities





 

Debenture stocks



(15,000)

    (25,000)

Unsecured loan notes



(49,795)

-




-----------

-----------




(64,795)

(25,000)




-----------

-----------

Net assets



712,633

668,196




=======

=======






Equity attributable to equity shareholders





Share capital (note 7)



28,271

28,027

Share premium account



12,722

7,053

Capital redemption reserve



12,489

12,483

Retained earnings:





  Other capital reserves



624,099

587,744

  Revenue reserve



35,052

32,889




-----------

-----------

Total equity



712,633

668,196




=======

=======

Net asset value per ordinary share (pence) 

- basic and diluted (Note 8)



 

630.2p

 

596.0p




======

======






 

 

 

 

CASH FLOW STATEMENT

 

 

Reconciliation of profit before taxation to

net cash flow from operating activities

At 31 October

2015

£'000

At 31 October

2014

£'000

Operating activities



Profit before taxation

56,678

26,705

Add back interest payable ("finance costs")

3,082

2,283

Amortisation of loan note issue costs

5

-

Less gains on investments held at fair value through profit or loss

(40,745)

(11,615)

Increase in accrued income

(70)

(345)

(Increase)/decrease in other receivables

(46)

12

Increase in other payables

59

50

Purchases of investments

(185,007)

(319,724)

Sales of investments

184,706

301,007

Purchases of current asset investments

(61,777)

(24,770)

Sales of current asset investments

37,350

20,895

Decrease in securities sold for future settlement

1,263

14,553

Decrease in securities purchased for future settlement

(1,077)

(6,373)


------------

------------




Net cash (outflow)/inflow from operating activities before interest and taxation

(5,579)

 

2,678

Interest paid

(2,291)

(2,282)

Taxation on investment income

(672)

(880)


------------

------------

Net cash outflow from operating activities

(8,542)

(484)




Financing activities



Equity dividends paid

(17,150)

(16,209)

Share issue

5,919

4,914

Buy-back of own shares

(155)

-

(Repayment)/drawdown of loan

(2,947)

2,874

New unsecured loan note issued

49,790

-


------------

------------

Net cash inflow /(outflow) from financing activities

35,457

(8,421)


------------

------------




Increase/(decrease) in cash

26,915

(8,905)

Cash and cash equivalents at start of the year

5,023

14,130

Exchange movements

(176)

(202)


------------

------------

Cash and cash equivalents at end of the year

31,762

5,023


========

=======

 

 

 

 

 

NOTES:

 

1.

Accounting policies


The financial statements for the year ended 31 October 2015 have been prepared in accordance with the International Financial Reporting Standards ("IFRSs") as adopted by the European Union and with those parts of the Companies Act 2006 applicable to companies reporting under IFRSs.  IFRSs comprise standards and interpretations approved by the International Accounting Standards Board ("IASB"), together with interpretations of the International Accounting Standards and Standing Interpretations Committee approved by the International Accounting Standards Committee ('IASC') that remain in effect, to the extent that IFRSs have been adopted by the European Union.

 

The financial statements have been prepared on a going concern basis and on the historical cost basis, except for the measurement at fair value of investments. The principal accounting policies adopted are set out in the audited accounts and have been applied consistently throughout the year.  Where presentational guidance set out in the Statement of Recommended Practice ("the SORP") for investment trusts issued by the Association of Investment Companies ("the AIC") in January 2009 is consistent with the requirements of IFRSs, the Directors have sought to prepare the financial statements on a basis consistent with the recommendations of the SORP.

 

Having assessed the principal risks and the other matters discussed in connection with the viability statement, the Directors considered it appropriate to adopt the going concern basis of accounting in preparing the financial statements.

 



2015

2014

2.

Investment income

£'000

£'000


UK dividend income  - listed

8,370

8,490


UK dividend income  - special dividends

2,011

638


Overseas dividend income - listed

11,872

11,115


Overseas dividend income - special dividends

188

206


Property income distributions

180

128



--------

--------



22,621

20,577



=====

=====


Analysis of investment income by geographical region:




UK

12,841

11,119


Europe (ex UK)

                     2,306

2,271


North America

2,193

1,734


Japan

1,345

1,304


China

997

1,501


Pacific (ex Japan, China)

2,510

2,165


Emerging markets

429

483



--------

---------



22,621

20,577



=====

=====

 

 



 

 



2015

2014

3.

Other operating income

£'000

£'000


Bank interest

39

19


Underwriting revenue

41

69


Stock lending revenue

66

83



--------

--------



146

171



=====

=====

 


At 31 October 2015 the total value of securities on loan by the Company for stock lending purposes was £50,889,000 (2014: £31,281,000). The maximum aggregate value of securities on loan at any one time during the year ended 31 October 2015 was £69,710,000 (2014: £38,547,000). The Company's agent held collateral at 31 October 2015 with a value of £56,493,000 (2014: £32,955,000) in respect of securities on loan. The value of securities held on loan is reviewed on a daily basis, comprising CREST Delivery By Value ("DBVs") and Government Bonds with a market value of 105% (2014: 105%) of the market value of any securities on loan.

 

 

 

 

4.

 

 

 

Management fees

Revenue return

2015

£'000

Capital

return

2015

£'000

 

Total

2015

£'000

Revenue return

2014

£'000

Capital

return

2014

£'000

 

Total

2014

£'000


Investment management

892

2,082

2,974

398

929

1,327


Accounting, secretarial and administration

 

-

 

-

 

-

 

1,328

 

-

 

1,328



-------

-------

-------

-------

-------

-------



892

2,082

2,974

1,726

929

2,655



====

====

====

====

====

====


 

A summary of the terms of the management agreement is given in the Strategic Report in the Annual Report and financial statements.

  

 

 

 

 

 

5.

 

 

 

Taxation

Revenue return

2015

£'000

Capital

return

2015

£'000

 

Total

2015

£'000

Revenue return

2014

£'000

Capital

return

2014

£'000

 

Total

2014

£'000


(a) Analysis of the charge for the year
















Overseas tax suffered

956

6

962

906

-

906


Overseas tax reclaimable

(107)

-

(107)

(131)

-

(131)



-------

-------

-------

-------

-------

-------


Taxation

849

6

855

775

-

775



====

====

====

====

====

====

 

 

 

 

 

 

 

 

 

 


(b) Factors affecting the tax charge for the year

The differences are explained below:

 



Revenue return

2015

£'000

Capital

return

2015

£'000

 

Total

2015

£'000

Revenue return

2014

£'000

Capital

return

2014

£'000

 

Total

2014

£'000


Profit before taxation

20,162

36,516

56,678

17,617

9,088

26,705



---------

-----------

-----------

---------

-----------

-----------


Corporation tax for the year at 20.42% (2014: 21.83%)

4,117

7,457

11,574

 

3,846

 

1,984

 

5,830


 

Non taxable UK dividends

(2,097)

-

(2,097)

 

(1,970)

 

-

 

(1,970)


 

Non taxable scrip dividends and other income

(2,370)

-

(2,370)

 

 

(2,422)

 

 

-

 

 

(2,422)

 

 

Income taxable in different years

(4)

-

(4)

 

(2)

 

-

 

(2)


Overseas withholding tax suffered

849

6

855

 

775

 

-

 

775


Excess management expenses and loan relationships

353

-

353

 

           

548

 

 

552

 

 

1,100


Disallowable expenses

1

-

1

-

-

-


Capital gains not subject to tax

-

(7,457)

(7,457)

 

-

 

(2,536)

 

(2,536)



--------

-----------

-----------

--------

-----------

----------



849

6

855

775

-

775



====

======

=====

====

======

=====

 


(c) Provision for deferred taxation

No provision for deferred taxation has been made in the current year or in the prior year.  The Company has not provided for deferred tax on capital gains or losses arising on the revaluation or disposal of investments as it is exempt from tax on these items because of its status as an investment trust company, which it intends to maintain for the foreseeable future.




(d) Factors that may affect future tax charges

The Company has not recognised a deferred tax asset of £6,561,000 (2014: £5,374,000) arising as a result of having unutilised management expenses £12,690,000 (2014: £9,658,000) and loan relationship deficits of £20,115,000 (2014: £17,210,000). These expenses will only be utilised, to any material extent, if changes are made either to the tax treatment of the capital gains made by investment trusts or to the Company's investment profile which require them to be used.

 

The standard rate of corporation tax in the UK changed from 21% to 20% with effect from 1 April 2015. Accordingly, the Company's profits for this accounting period are taxed at the effective rate of tax of 20.42%.

 

6.

Earnings per ordinary share


The total earnings per ordinary share is based on the net profit attributable to the ordinary shares of £55,823,000 (2014: £25,930,000) and on 112,178,757 ordinary shares (2014: 111,898,962), being the weighted average number of shares in issue during the year.

 

 

 

 

 

 

 

 

 

The total earnings can be further analysed as follows:

 



2015

2014



£'000

£'000


Revenue profit

19,313

16,842


Capital profit

36,510

9,088



----------

----------


Profit for the year

55,823

25,930



----------

----------






Weighted average number of ordinary shares

112,178,757

111,898,962



----------------

----------------






Revenue earnings per ordinary share

17.22p

15.05p


Capital earnings per ordinary share

32.54p

8.12p



----------

----------


Earnings per ordinary share

49.76p

23.17p



=======

=======






The Company does not have any dilutive securities, therefore basic and diluted earnings are the same.

 

 

7.

 

Called up share capital

2015

£'000

2014

£'000


Authorised, allotted, issued and fully paid:




 113,081,839 (2014: 112,106,839) ordinary shares of 25p each

28,271

 

28,027



=====

=====






During the year, 1,000,000 ordinary shares were issued for net proceeds of £5,919,000 (2014: 850,000 issued for net proceeds of £4,914,000). Also during the year, 25,000 ordinary shares were purchased for cancellation at a cost of £155,000 (2014: nil).

 

Since the year end, the Company issued a further 1,450,000 ordinary shares for net proceeds of £9,086,000.

 

8.

Net asset value per ordinary share


The net asset value per ordinary share is based on net assets attributable to ordinary shares of £712,633,000 (2014: £668,196,000) and on the 113,081,839 ordinary shares in issue at 31 October 2015 (2014: 112,106,839). The Company has no securities in issue that could dilute the net asset value per ordinary share.

 

The movements during the year in net assets attributable to the ordinary shares were as follows:

           



2015

2014



£'000

£'000


Net assets attributable to ordinary shares at start of year

668,196

653,561


Total net profit on ordinary activities after taxation

55,823

25,930


Dividends paid

(17,150)

(16,209)


Issue of ordinary shares

5,919

4,914


Purchase of ordinary shares

(155)

-



------------

------------


Net assets attributable to ordinary shares at end of year

712,633

668,196



======

======

 



 

 

9.

2015 Financial Information


The figures and financial information for the year ended 31 October 2015 are extracted from the Company's annual financial statements for that period and do not constitute statutory accounts.  The Company's annual financial statements for the year to 31 October 2015 have been audited but have not yet been delivered to the Registrar of Companies.  The Auditors' report on the 2015 annual financial statements was unqualified, did not include a reference to any matter to which the Auditors drew attention without qualifying the report, and did not contain any statements under Section 498 of the Companies Act 2006.



10.

2014 Financial Information


The figures and financial information for the year ended 31 October 2014 are compiled from an extract of the published accounts for that year and do not constitute statutory accounts.  Those accounts have been delivered to the Registrar of Companies and included the report of the Auditors which was unqualified and did not contain a statement under Sections 498(2) or 498(3) of the Companies Act 2006.



11.

Dividend


 A final dividend of 4.00p per ordinary share will be paid, if approved by shareholders at the AGM, on 29 February 2016 to shareholders on the register on 29 January 2016.   The Company's shares go ex-dividend on 28 January 2016.



12.

Annual Report and Financial Statements


Copies of the Annual Report and financial statements will be posted to shareholders by the end of January 2016 and will be available on the Company's website

(www.bankersinvestmenttrust.com) or in hard copy format from the Registered Office,

201 Bishopsgate, London EC2M 3AE. 



13.

Annual General Meeting

The Annual General Meeting will be held on Thursday 25 February 2016 at 12 noon at Trinity House, London, EC3N 4DH.

 

 

 

 

 

 

LARGEST INVESTMENTS at 31 October 2015

The 25 largest investments (convertibles and all classes of equity in any one company being treated as one investment) were as follows:

 

 

 

Rank

 

 

(2014)


Valuation

2014

£'000

 

Purchases

£'000

Sales proceeds

£'000

 

Appreciation/ (depreciation)

£'000

Valuation

2015

£'000

1

(1)

BP

15,335

-

-

(2,138)

13,197

2

(2)

British American Tobacco

9,932

-

-

875

10,807

3

(6)

Delphi Automative

8,301

322

-

2,120

10,743

4

(13)

Apple

7,635

1,247

-

1,162

10,044

5

(11)

ITV

8,009

-

-

1,948

9,957

6

(5)

Sports Direct International

9,066

-

-

738

9,804

7

(10)

Galliford Try

8,013

1,009

(1,522)

1,808

9,308

8

(12)

Barclays

7,795

1,551

-

(365)

8,981

9

(9)

American Tower

8,090

-

-

695

8,785

10

(17)

BT

6,875

-

-

1,824

8,699

11

#

CVS Health

4,830

2,719

-

1,072

8,621

12

(8)

Royal Dutch Shell

8,094

2,596

-

(2,156)

8,534

13

#

Roper Technologies

4,279

2,753

-

1,458

8,490

14

#

Fresenius

3,358

3,548

(453)

1,972

8,425

15

#

Cardinal Health

-

8,218

-

(301)

7,917

16

(15)

Comcast

7,515

1,534

(2,355)

933

7,627

17

(24)

Reckitt Benckiser

6,300

-

-

1,313

7,613

18

#

Fidelity National Information Services

3,052

2,583

-

1,617

7,252

19

#

Persimmon

2,926

2,662

-

1,401

6,949

20

#

The Cooper Companies

4,546

2,674

-

(359)

6,861

21

#

Accenture

3,930

1,027

-

1,743

6,700

22

(21)

GlaxoSmithKline

6,576

-

-

(58)

6,518

23

(7)

HSBC

8,174

-

-

(1,686)

6,488

24

(18)

American Express

6,822

772

-

(1,204)

6,390

25

#

Visa

2,855

2,111

-

1,333

6,299












-----------

-----------

-----------

-----------

-----------




162,308

37,286

(4,330)

15,745

211,009




======

======

======

======

======

 

All securities are equity investments

 

# Not in the top 25 last year.

 

CHANGES IN INVESTMENTS at 31 October 2015

 


Valuation

2014

£'000

 

Purchases£'000

Sales proceeds

£'000

Appreciation/

(depreciation) £'000

Valuation

2015

£'000

United Kingdom

281,599

13,406

(25,334)

7,567

277,238

Europe

78,035

19,256

(59,264)

54,994

93,021

North America

153,925

67,342

(11,876)

(31,670)

177,721

Japan

60,287

31,454

(21,391)

14,214

84,564

China

16,642

28,366

(36,011)

14,089

23,086

Pacific (ex Japan, China)

75,847

20,655

(25,618)

(12,097)

58,787

Emerging Markets

19,121

4,638

(5,211)

(6,134)

12,414


-----------

-----------

------------

-----------

-----------


685,456

185,117

(184,705)

40,963

726,831


======

======

=======

======

======

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

******


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR UWRSRNUAAAAR
UK 100

Latest directors dealings